Evidence map›Paper›PMID 28968825›Full record

ArticleRheumatology (Oxford, England)2017

Treating experimental arthritis with the innate immune inhibitor interleukin-37 reduces joint and systemic inflammation.

Giulio Cavalli, Marije Koenders, Vassili Kalabokis, Jihye Kim, Aik Choon Tan, Cecilia Garlanda, Alberto Mantovani, Lorenzo Dagna, Leo A B Joosten, Charles A Dinarello

Abstract readPublished Erratum
In one paragraph

Article in Rheumatology (Oxford, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Deregulated Expression ofInternational journal of molecular sciences · 2023
    Article
  3. Article
  4. Article
  5. Plasma levels of IL-1β and IL-37 in patients with severe haemophilia.The Journal of international medical research · 2020
    Article
  6. Article
  7. Role for nuclear interleukin-37 in the suppression of innate immunity.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  8. Review
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Giulio CavalliDepartment of Medicine, University of Colorado Denver, Aurora, CO, USA.
Marije KoendersDepartment of Rheumatology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Vassili KalabokisR&D Systems, BioTechne, Inc., Minneapolis, MN.
Jihye KimTranslational Bioinformatics, Division of Medical Oncology, University of Colorado Denver, Aurora, CO, USA.
Aik Choon TanTranslational Bioinformatics, Division of Medical Oncology, University of Colorado Denver, Aurora, CO, USA.
Cecilia GarlandaResearch Institute Humanitas, Experimental Immunopathology Lab, Rozzano, Italy.
Alberto MantovaniResearch Institute Humanitas, Experimental Immunopathology Lab, Rozzano, Italy.
Lorenzo DagnaInternal Medicine and Clinical Immunology, Vita-Salute San Raffaele University, Milan, Italy.
Leo A B JoostenDepartment of Internal Medicine.
Charles A DinarelloDepartment of Medicine, University of Colorado Denver, Aurora, CO, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID28968825
PMCPMC6262238

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.